Table 1.
Patient demographics and baseline characteristics
90 mg/m2 (n = 3) | 120 mg/m2 (n = 6) | All patients (n = 9) | |
---|---|---|---|
Sex | |||
Male | 2 | 3 | 5 |
Female | 1 | 3 | 4 |
Age (years) | |||
20–29 | 0 | 0 | 0 |
30–39 | 0 | 1 | 1 |
40–49 | 1 | 2 | 3 |
50–59 | 0 | 1 | 1 |
60–69 | 2 | 2 | 4 |
Histology (WHO classification) | |||
Follicular | 2 | 6 | 8 |
MCL | 1 | 0 | 1 |
Clinical stage (Ann Arbor classification) | |||
I | 1 | 2 | 3 |
II | 1 | 1 | 2 |
III | 0 | 2 | 2 |
IV | 1 | 1 | 2 |
Number of previous regimens | |||
1 | 1 | 2 | 3 |
2 | 0 | 3 | 3 |
3+ | 2 | 1 | 3 |
MCL, mantle cell lymphoma; WHO, World Health Organization.